These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8140017)

  • 21. Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome.
    Asherson RA; Giampaulo D; Singh S; Sulman L
    J Clin Rheumatol; 2007 Jun; 13(3):173-4. PubMed ID: 17551389
    [No Abstract]   [Full Text] [Related]  

  • 22. Warfarin and hydroxyethylrutosides in deep vein thrombosis.
    Eastham RD; Perham TG; Pocock PV
    Br Med J; 1972 Nov; 4(5838):491. PubMed ID: 4653895
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
    N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporary resistance to heparin and warfarin in treatment of deep vein thrombosis.
    Viswanathan B
    J Kans Med Soc; 1980 Oct; 81(10):468-9. PubMed ID: 7229498
    [No Abstract]   [Full Text] [Related]  

  • 25. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flunarizine v. placebo in childhood migraine. A double-blind study.
    Sorge F; Marano E
    Cephalalgia; 1985 May; 5 Suppl 2():145-8. PubMed ID: 2861907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic optimisation of the treatment of deep vein thrombosis.
    Iorio A; Agnelli G
    Clin Pharmacokinet; 1997 Feb; 32(2):145-72. PubMed ID: 9068929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for preventing migraine headaches in children.
    Victor S; Ryan SW
    Cochrane Database Syst Rev; 2003; (4):CD002761. PubMed ID: 14583952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
    Donaldson D; Sundermann R; Jackson R; Bastani A
    Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphenhydramine as Adjuvant Therapy for Acute Migraine: An Emergency Department-Based Randomized Clinical Trial.
    Friedman BW; Cabral L; Adewunmi V; Solorzano C; Esses D; Bijur PE; Gallagher EJ
    Ann Emerg Med; 2016 Jan; 67(1):32-39.e3. PubMed ID: 26320523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
    Aurora SK; Dodick DW; Turkel CC; DeGryse RE; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Cephalalgia; 2010 Jul; 30(7):793-803. PubMed ID: 20647170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks.
    Kloster R; Nestvold K; Vilming ST
    Cephalalgia; 1992 Jun; 12(3):169-71; discussion 128. PubMed ID: 1623513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propranolol in acute migraine: a controlled study.
    Fuller GN; Guiloff RJ
    Cephalalgia; 1990 Oct; 10(5):229-33. PubMed ID: 2272092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.